RBC Capital Markets adjusted their outlook on Morgan Stanley (NYSE:MS) shares, raising the price target from $122.00 to ...
RBC Capital analyst Arun Viswanathan maintained a Buy rating on Ball (BALL – Research Report) yesterday and set a price target of $75.00. The ...
RBC Capital Markets adjusted its stance on Intra-Cellular Therapies shares, downgrading the biopharmaceutical company from Outperform to Sector Perform. The firm, however, raised its price target on ...
In a report released yesterday, Deane Dray from RBC Capital maintained a Sell rating on 3M (MMM – Research Report), with a price target of ...
“We think Morgan Stanley benefits from favorable secular trends in the capital markets, wealth management, and investment banking,” he said in a research note. Morgan Stanley’s revenue from ...
NEW YORK--(BUSINESS WIRE)--Morgan Stanley Investment Management today announced that, effective immediately, the Morgan Stanley Emerging Markets Debt Fund, Inc. (NYSE: MSD) (the “Fund”) is no ...
Research analysts at BMO Capital Markets began coverage on shares of Toast (NYSE:TOST – Get Free Report) in a report released on Monday,Benzinga reports. The brokerage set an “outperform” rating and a ...